Immune Attack Articles & Analysis
19 news found
CAR-T (chimeric antigen receptor T-cell) and CAR-NK (chimeric antigen receptor natural killer cell) therapies involve genetically modifying a patient's own immune cells to recognize and attack cancer cells more efficiently. By engineering these cells to express specific receptors on their surface, they acquire enhanced targeting capabilities against malignant ...
"Our AI platform basically mimics the human immune system using AI," said Ofran. "For this program, we chose the IL-2 pathway, which is well-studied and extensively explored. The antibody that is entering the clinic now was designed based on our understanding of the IL-2 pathway. We know IL-2 activates the immune system to attack the tumor, but ...
IO-108 is being studied as a monotherapy and in combination with select anti-PD-1 antibodies in multiple expansion cohorts of solid tumors Clinical supply agreement with Regeneron accelerates Immune-Onc’s solid tumor clinical development program Immune-Onc Therapeutics, Inc. ...
About ImmCelz ImmCelz®, which is protected by trade secrets and published U.S. patents, utilizes adult stem cells derived from qualified donors to endow specific properties to the patient's immune cells. After the patient's harvested cells are incubated with the Company's cell-free reprogramming "cocktail", the cells are re-injected back into the patient. These "supercharged" ...
“We currently manage high-level BK viremia by reducing immunosuppressive therapy, which can help a patient’s immune system clear the virus, but this approach raises the risk that the immune system will attack and reject the graft. The potential for posoleucel to specifically restore immunity to BKV as an alternative ...
ByKalaris
Immunotherapies are designed to restore the body’s own complex immune and defense mechanisms to recognize and destroy cancer cells. Checkpoint inhibitor therapy targets immune checkpoints, which are key regulators of the immune system that stimulate or inhibit its actions. Tumors can use these key regulators to protect themselves from ...
Usually a certain protein in the food is not welcomed by the patient’s body, generating a severe immune reaction. The body analyzes that protein as a foreign particle or antigen and attacks it with the help of immune cells. Allergic reactions are mediated by IgE type immune response. The IgE antibodies are formed on the ...
About ImmCelz ImmCelz®, which is protected by trade secrets and published U.S. patents, utilizes adult stem cells derived from qualified donors to endow specific properties to the patient's immune cells. After the patient's harvested cells are incubated with the Company's cell-free reprogramming "cocktail", the cells are re-injected back into the patient. These "supercharged" ...
“Clinical data previously collected by Cancer Research UK demonstrated peripheral immunogenicity in patients with NSCLC treated with VAC2, providing support to the underlying mechanism of using allogeneic dendritic cells to present tumor-associated antigens to the body’s immune system. Simultaneous with Cancer Research UK efforts to complete enrollment in the current ...
SCIB1 is the lead product from the Company’s ImmunoBody® immunotherapy platform, which uses the body’s immune system to identify, attack and destroy tumours. This is achieved by delivering a DNA plasmid using Ichor’s TriGrid® 2.0 electroporation delivery device to enhance the uptake and presentation of cancer antigens to harness high ...
ByScancell
ImmCelz®, which is protected by trade secrets and published U.S. patents, utilizes adult stem cells derived from qualified donors to endow specific properties to the patient's immune cells. After the patient's harvested cells are incubated with the Company's cell-free reprogramming "cocktail", the cells are re-injected back into the patient. These "supercharged" cells ...
Cipla also recently launched a biosimilar for the treatment of immune-mediated inflammatory disease. According to the Cancer Alliance report CA03/2021, South Africa faces a crisis in terms of affordable access to medicines, particularly in the treatment of cancer. ...
These are so-called prophylactic vaccines that teach the immune system to attack and get rid of hostile “invaders in the body” before disease can develop. During the last ten years, research has made great strides towards the application of such immunization strategies also in a more therapeutic fashion, so to treat already existing ...
VTP-600 is an immunotherapy, designed to stimulate the body’s immune system to attack cancer cells. It does this by delivering cancer-associated proteins — known as MAGE-A3 and NY-ESO-1 antigens — to antigen presenting cells (dendritic cells), causing the immune system to produce cytotoxic T cells which are able to target and ...
” The GammabodyTM LAVA-051 is a bispecific antibody that recruits the immune system to attack CD1d-expressing cancer cells via the preferential activation of both Gamma Delta T cells and type 1 natural killer T (NKT) cells. ...
Cancer immunotherapy is seen as a turning point in the fight against cancer: Unlike traditional therapies that attack the tumor directly, T3 Pharma’s immunotherapy stimulates the immune system to selectively recognize and attack tumor cells. ...
KEYTRUDA is an immunotherapy that blocks the interaction between PD-1 and its ligands, PD-L1 and PD-L2, thereby helping the immune system do what it is meant to do: help detect and fight cancer cells. KEYTRUDA can also cause the immune system to attack normal organs and tissues. The FDA today approved PD-L1 IHC 22C3 pharmDx for use in the United ...
It's helping to keep their homes clean when their immune systems are under attack. The Cleaning for a Reason Foundation (www.cleaningforareason.org) offers professional housecleaning services once a month for four months to women undergoing treatment for cancer - at no cost. ...
GM-CSF complements the cancer cell lysis work of the product candidate, leading to a cascade of events resulting in tumor necrosis, tumor vasculature shutdown and an anti-tumoral immune attack. About Jennerex Jennerex is a clinical-stage biopharmaceutical company focused on the development and commercialization of first-in-class, breakthrough targeted ...